Accelerated Approval 21 CFR (314 and 601) Accelerated Approval Rule, 1992. Serious or life-threatening illness.
{"Image DocumentName": "Accelerated Approval21 CFR (314 and 601) Accelerated Approval Rule, Serious or life-threatening illness.", "Image ImageDescription": "Surrogate or non-ultimate clinical endpoints. Post-marketing data required to verify and describe the drug\u2019s clinical benefit and to resolve remaining uncertainty as to the relation of the surrogate endpoint upon which approval was based to clinical benefit, or the observed clinical benefit to ultimate outcomes.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}